Open AccessClinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer
Author(s) -
Sasagu Kurozumi,
Ayaka Katayama,
Ken Shirabe,
Jun Horiguchi,
Emad A. Rakha
Publication year - 2021
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.28007
Subject(s) - triple negative breast cancer , medicine , breast cancer , human epidermal growth factor receptor 2 , cancer , epidermal growth factor receptor , oncology , cancer research
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom